StockWatch
·
Pharmaceuticals
Quarterly Result30 Oct 2026, 05:53 pm

Lyka Labs Q2 FY27 Revenue Up 34% Standalone

AI Summary

Lyka Labs Limited announced its unaudited financial results for the second quarter and half-year ended September 30, 2026. For Q2 FY27, standalone revenue from operations increased by 34.06% to Rs. 4,419.95 Lacs, and consolidated revenue grew by 20.56% to Rs. 4,419.95 Lacs. Standalone EBITDA margin improved to 9.49% from (5.63)% in Q2 FY26, with consolidated EBITDA margin at 9.37% compared to (3.95)% in the prior year. Standalone net profit surged by 136.32% to Rs. 131.50 Lacs, and consolidated net profit rose by 139.54% to Rs. 127.11 Lacs. For H1 FY27, standalone revenue grew 39.20% to Rs. 8,650.89 Lacs, and consolidated revenue increased 24.14% to Rs. 8,650.89 Lacs. Standalone net profit for H1 FY27 was Rs. 341.53 Lacs, up 221.55%, and consolidated net profit was Rs. 331.77 Lacs, up 249.57%. Domestic revenue saw a 12.89% increase in Q2 FY27, while export revenue grew by 51.89%.

Key Highlights

  • Standalone revenue up 34.06% to Rs. 4,419.95 Lacs in Q2 FY27.
  • Net profit surged 136.32% to Rs. 131.50 Lacs in Q2 FY27.
  • EBITDA margins improved significantly year-on-year.
  • Export revenue grew by 51.89% in Q2 FY27.
  • H1 FY27 net profit increased by over 200%.